Celyad Oncology Sa Stock Price Prediction
| CLYYF Stock | USD 0.15 0.00 0.00% |
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Celyad Oncology hype-based prediction, you can estimate the value of Celyad Oncology SA from the perspective of Celyad Oncology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Celyad Oncology to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Celyad because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Celyad Oncology after-hype prediction price | USD 0.15 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Celyad |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Celyad Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Celyad Oncology After-Hype Price Density Analysis
As far as predicting the price of Celyad Oncology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Celyad Oncology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Celyad Oncology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Celyad Oncology Estimiated After-Hype Price Volatility
In the context of predicting Celyad Oncology's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Celyad Oncology's historical news coverage. Celyad Oncology's after-hype downside and upside margins for the prediction period are 0.01 and 2.58, respectively. We have considered Celyad Oncology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Celyad Oncology is out of control at this time. Analysis and calculation of next after-hype price of Celyad Oncology SA is based on 3 months time horizon.
Celyad Oncology Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Celyad Oncology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Celyad Oncology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Celyad Oncology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.42 | 2.43 | 0.00 | 0.02 | 0 Events / Month | 7 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.15 | 0.15 | 0.00 |
|
Celyad Oncology Hype Timeline
Celyad Oncology SA is currently traded for 0.15. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.02. Celyad is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is currently at -0.42%. %. The volatility of related hype on Celyad Oncology is about 4900.84%, with the expected price after the next announcement by competition of 0.13. About 24.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.51. Celyad Oncology SA had not issued any dividends in recent years. Assuming the 90 days horizon the next anticipated press release will be in 5 to 10 days. Check out Celyad Oncology Basic Forecasting Models to cross-verify your projections.Celyad Oncology Related Hype Analysis
Having access to credible news sources related to Celyad Oncology's direct competition is more important than ever and may enhance your ability to predict Celyad Oncology's future price movements. Getting to know how Celyad Oncology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Celyad Oncology may potentially react to the hype associated with one of its peers.
Celyad Oncology Additional Predictive Modules
Most predictive techniques to examine Celyad price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Celyad using various technical indicators. When you analyze Celyad charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Celyad Oncology Predictive Indicators
The successful prediction of Celyad Oncology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Celyad Oncology SA, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Celyad Oncology based on analysis of Celyad Oncology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Celyad Oncology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Celyad Oncology's related companies.
Currently Active Assets on Macroaxis
Complementary Tools for Celyad Pink Sheet analysis
When running Celyad Oncology's price analysis, check to measure Celyad Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celyad Oncology is operating at the current time. Most of Celyad Oncology's value examination focuses on studying past and present price action to predict the probability of Celyad Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celyad Oncology's price. Additionally, you may evaluate how the addition of Celyad Oncology to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |